4
Changes in Ownership
REGENXBIO Inc. Filed Acc 0001562180-24-006013
Chief Scientific Officer acquired 60,230 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Danos Olivier · Chief Scientific Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-06-28 | Grant or award : show line 1 in the form | +1,363 | $9.95 | $13,555 | 126,216 | D |
| 2024-08-01 | Grant or award : show line 2 in the form | +58,867 | 185,083 | D |
Loading xslF345X05/primarydocument.xml…